WuXi Biologics
End-to-End Biologic CDMO Solutions
Global biologic CDMO offering end-to-end solutions from discovery to commercialization.
Modalities
Development & manufacturing
Structured CDMO capabilities from verified public sources.
Development (D)
Manufacturing (M)
Services
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Process Development
- CMC Analytical Development
- Formulation Development
- Technology Transfer
- Quality Control Testing
- CMC Regulatory Submission Support
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Microbial Fermentation
- Biologics Development & Manufacturing
- Stability Testing & Storage
About this organization
WuXi Biologics is a global biologic contract development and manufacturing organization (CDMO) providing end-to-end solutions spanning discovery through commercialization.
Locations
Headquarters
Recent news about WuXi Biologics
Biologics CDMO capacity is expanding, but not fast enough for the reshuffled supply chain in 2026
Oct 15, 2026
Fill finish drug product CDMO outsourcing capacity
Aug 20, 2026
Transcenta Sells Hangzhou GMP Plant to WuXi Biologics for $26.2M
Aug 11, 2026
Modern Catalyst
Jul 23, 2026
WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility
Jun 6, 2026
Related companies
Similar profiles by shared services, modalities, and capabilities.
KBI Biopharma, Inc.- Cell-Line Development
- Upstream Processing
Celonic- Cell-Line Development
- Upstream Processing
Avid Bioservices- Cell-Line Development
- Upstream Processing
Biocon- Upstream Processing
- Downstream Processing
Wheeler Bio- Cell-Line Development
- Process Development
FUJIFILM Biotechnologies- Cell-Line Development
- Upstream Processing
Enzene Biosciences- Cell-Line Development
- Process Development
Bionova Scientific- Cell-Line Development
- Upstream Processing
Submit a verified review for this organization.
Markdown mirror: /companies/wuxibiologics.md